SCHEMBL21907324

SCHEMBL21907324

Bc1c(B)c(B)c2c(-c3ccc(-c4ccc5oc6ccccc6c5c4)cc3)c3c(B)c(B)c(B)c(B)c3c(-c3ccccc3)c2c1B

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 6/20 0.47
PLA2G4A P47712 6/20 0.47
NPC1 O15118 2/20 0.42
HPGD P15428 2/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MAPT P10636 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
KMT2A Q03164 1/20 0.42
PLA2G10 O15496 1/20 0.42
AHR P35869 2/20 0.39
PTPN1 P18031 1/20 0.39
PRKDC P78527 2/20 0.39
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
LMNA P02545 1/20 0.37
CASP3 P42574 1/20 0.36
SENP7 Q9BQF6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24479342 1.00 PLA2G2A (0.47) PLA2G2APLA2G4ANPC1HPGDRAB9A
SCHEMBL24479799 1.00 PLA2G2A (0.47) PLA2G2APLA2G4ANPC1HPGDRAB9A
SCHEMBL21906986 0.97 PLA2G2A (0.43) PLA2G2APLA2G4ANPC1HPGDRAB9A
SCHEMBL25007208 0.97 PLA2G2A (0.43) PLA2G2APLA2G4ANPC1HPGDRAB9A
SCHEMBL24766989 0.96 PLA2G2A (0.45) PLA2G2APLA2G4ANPC1HPGDRAB9A
SCHEMBL21906930 0.95 MAPT (0.44) PLA2G2APLA2G4ANPC1HPGDRAB9A
SCHEMBL21906987 0.94 PLA2G2A (0.46) PLA2G2APLA2G4ANPC1HPGDRAB9A
SCHEMBL21907986 0.94 PLA2G2A (0.46) PLA2G2APLA2G4ANPC1HPGDRAB9A
SCHEMBL25957146 0.93 PLA2G2A (0.40) PLA2G2APLA2G4ANPC1HPGDRAB9A
SCHEMBL24479325 0.92 PLA2G2A (0.41) PLA2G2APLA2G4ANPC1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230200226-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-22 US disclosed
US-20230165138-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-05-25 US disclosed
US-20230145611-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT IDEMITSU KOSAN CO.,LTD. (JP) 2023-05-11 US disclosed
US-20230011996-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2023-01-12 US disclosed
US-20220411437-A1 NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 US disclosed
US-20220169656-A1 NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO., LTD. (JP) 2022-06-02 US disclosed
US-10804474-B2 Organic electroluminescence device and electronic apparatus provided with the same IDEMITSU KOSAN CO., LTD. (JP) 2020-10-13 US disclosed
US-10763444-B2 Organic electroluminescence device and electronic apparatus provided with the same IDEMITSU KOSAN CO., LTD. (JP) 2020-09-01 US disclosed
US-20200111974-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2020-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411437-A1 NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS RPS19, TERT, PIEZO1 PLA2G2A 3253/4885PLA2G4A 4215/4885NPC1 2643/4885
US-20230011996-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME RER1, RPS19, ESR1 PLA2G2A 3388/4885PLA2G4A 4378/4885NPC1 2777/4885
US-20220169656-A1 NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS RPS19, TERT, PIEZO1 PLA2G2A 3253/4885PLA2G4A 4215/4885NPC1 2643/4885
US-20230165138-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE PIEZO1, OR10J3, RIF1 PLA2G2A 4745/4885PLA2G4A 4864/4885NPC1 2851/4885
US-20230200226-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS L1CAM, LEF1, PIEZO1 PLA2G2A 3053/4885PLA2G4A 4115/4885NPC1 2696/4885
US-20230145611-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT LEF1, ETV6, SSB PLA2G2A 4311/4885PLA2G4A 4518/4885NPC1 3438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.